Literature DB >> 34734809

Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers.

Xue Geng1, Jidong Zhang1, Yanan Zhang1, Haijuan Hu1, Jing Yang1, Wei Cui1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34734809      PMCID： PMC8575395          DOI： 10.5152/AnatolJCardiol.2021.90

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  39 in total

1.  Beta-blocker therapy for heart failure: should the therapeutic target be dose or heart rate reduction?

Authors:  Robert L Huang; Jennifer Listerman; Joann Goring; Carrie Giesberg; Mary Alice Nading; Javed Butler
Journal:  Congest Heart Fail       Date:  2006 Jul-Aug

2.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

3.  Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril.

Authors:  B Sturm; R Pacher; J Strametz-Juranek; R Berger; B Frey; B Stanek
Journal:  Eur J Heart Fail       Date:  2000-12       Impact factor: 15.534

4.  Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.

Authors:  J N Cohn; M B Fowler; M R Bristow; W S Colucci; E M Gilbert; V Kinhal; S K Krueger; T Lejemtel; K A Narahara; M Packer; S T Young; T L Holcslaw; M A Lukas
Journal:  J Card Fail       Date:  1997-09       Impact factor: 5.712

5.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

Authors:  M R Bristow; E M Gilbert; W T Abraham; K F Adams; M B Fowler; R E Hershberger; S H Kubo; K A Narahara; H Ingersoll; S Krueger; S Young; N Shusterman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

6.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

7.  Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.

Authors:  S L Olsen; E M Gilbert; D G Renlund; D O Taylor; F D Yanowitz; M R Bristow
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

8.  Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.

Authors:  Anna Corletto; Hanna Fröhlich; Tobias Täger; Matthias Hochadel; Ralf Zahn; Caroline Kilkowski; Ralph Winkler; Jochen Senges; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

Review 9.  Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.

Authors:  Genevieve Flannery; Rosie Gehrig-Mills; Baki Billah; Henry Krum
Journal:  Am J Cardiol       Date:  2008-02-21       Impact factor: 2.778

10.  Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.

Authors:  M R Bristow; J B O'Connell; E M Gilbert; W J French; G Leatherman; N E Kantrowitz; J Orie; M L Smucker; G Marshall; P Kelly
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.